KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...
A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...
A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and difficult-to-treat cancers by harnessing dual-pathway nanoparticles that train the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback